A detailed history of Marshall Wace, LLP transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 144,042 shares of VIGL stock, worth $234,788. This represents 0.0% of its overall portfolio holdings.

Number of Shares
144,042
Holding current value
$234,788
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.92 - $4.65 $420,602 - $669,795
144,042 New
144,042 $489,000

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $46.1M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.